查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1820001

2025 年至 2033 年脊椎生物製劑市場報告（按產品、手術類型、最終用戶和地區）

Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球脊椎生物製劑市場規模達21.4億美元。展望未來， IMARC Group預計到2033年，市場規模將達到29.7億美元，2025-2033年期間的複合年成長率（CAGR）為3.52%。推動市場發展的因素包括：微創手術（MIS）的廣泛應用、老年人口的成長、收入水準提高帶來的醫療服務可近性的提升，以及脊椎疾病發生率的上升。

脊椎生物製劑市場分析：

  • 主要市場促進因素：脊椎生物製劑市場研究表明，市場主要受到椎間盤疾病和椎管狹窄等脊椎疾病盛行率不斷上升的推動，這些疾病通常與老化和生活方式因素有關。
  • 主要市場趨勢：隨著醫療技術的進步，脊椎手術中生物製劑的使用日益明顯，以促進患者更快康復並獲得更好的治療效果。在脊椎生物製劑市場預測中，該產業將見證人工智慧和機器學習技術的持續創新，從而提高脊椎生物製劑的精準度和有效性。
  • 地理趨勢：北美憑藉其先進的醫療基礎設施、高昂的醫療支出以及對脊椎疾病的認知度，目前在全球市場佔據領先地位。此外，根據脊椎生物製劑市場統計數據，由於醫療保健服務的普及、經濟水平的提高以及老年人口的成長，亞太地區正經歷快速成長。
  • 競爭格局：脊椎生物製劑產業的一些主要市場參與者包括 Arthrex Inc.、Alphatec Holdings Inc.、Exactech Inc.、強生、美敦力公司、NuVasive Inc.、Orthofix Medical Inc.、Stryker Corporation、Wright Medical Group NV 和 Zimmer Biomet 等。
  • 挑戰與機會：市場挑戰包括對生物製劑高成本的擔憂，以及可能導致產品上市延遲的嚴格監管環境。正如脊椎生物製劑市場概述所述，與保險公司和醫療機構日益增多的合作，有望改善生物製劑治療的可及性和應用，從而創造眾多機會。

脊椎生物製劑市場趨勢：

脊椎疾病盛行率不斷上升

脊椎疾病的日益增加影響著脊椎生物製劑市場的成長。此外，預期壽命的延長和生活方式的問題也刺激了椎間盤疾病和椎管狹窄等退化性疾病的發展。根據世界衛生組織 (WHO) 的數據，2020 年大約每 13 個人中就有 1 人（相當於 6.19 億人）患有腰痛 (LBP)，比 1990 年增加了 60%。據進一步估計，到 2050 年，腰痛病例將增加約 8.43 億，凸顯了脊椎問題的普遍性。 80 歲年齡層的發生率不斷上升，而 50-55 歲年齡層的 LBP 病例數則不斷增加。這種普遍的盛行率需要持續開發和部署有效的治療方法，包括生物製劑，這有助於促進骨骼生長和癒合，使其成為治療這些普遍存在的疾病的關鍵。

微創手術（MIS）的採用率不斷上升

與傳統的開放式手術相比，微創手術 (MIS) 因其痛苦小、恢復快而成為治療脊椎疾病的首選。根據 IMARC 集團的數據，預計 2024 年至 2032 年期間，全球微創手術市場將以約 6% 的年複合成長率(CAGR) 擴張。 2023 年，該市場規模達到 529 億美元，預計到 2032 年將達到 910 億美元。這一成長表明手術方法的轉變，從而縮短了住院時間和恢復期，這對脊椎生物製劑的市場價值尤其有利。

老年人口不斷增加

老年人口的成長推動了脊椎生物製劑市場的需求。隨著年齡的成長，脊椎疾病的風險也會增加，因此需要更頻繁、更深入的照護。根據聯合國的資料，預計65歲及以上人口的比例將從2022年的10%上升到2050年的16%。預計到2050年，全球65歲及以上人口的數量將是5歲以下兒童數量的兩倍，相當於12歲兒童的數量。這意味著與年齡相關的脊椎疾病數量將持續增加，對有效且微創的治療方法的需求也隨之增加。例如，有助於自然癒合過程的生物製劑尤其適合滿足這些需求，符合全球老化人口日益成長的醫療保健需求。

脊椎生物製劑市場細分：

按產品分類：

  • 脊椎同種異體移植
    • 機械加工骨同種異體移植
    • 去礦骨基質
  • 骨移植替代品
    • 骨形態發生蛋白
    • 合成骨移植
  • 基於單元格的矩陣

骨移植替代品佔大部分市場佔有率

骨移植替代品是傳統骨移植的替代方案，可在脊椎手術中提供結構支撐並促進骨癒合。這些替代品包括合成材料、同種異體骨和脫礦骨基質，因其能夠促進骨融合、減少從患者自身取骨的需求、最大限度地減少手術併發症和縮短恢復時間而備受推崇。根據IMARC GROUP的數據，全球骨移植和替代品市場規模在2023年達到32億美元。預計到2032年將達到51億美元，2024-2032年期間的年複合成長率（CAGR）為5.2%。此外，生物材料、再生醫學和骨移植替代品領域的各項進步正見證著其在脊椎手術中的應用日益廣泛，從而積極提升了脊椎生物製品市場的價值。

依手術類型分類：

  • 開放性脊椎手術
  • 微創脊椎手術

微創脊椎手術佔據業界最大佔有率

微創脊椎手術的興起主要歸功於患者和醫護人員對微創手術的日益青睞。與傳統的開放式手術相比，微創脊椎手術具有許多優勢，包括切口較小、出血量較少、住院時間較短、恢復較快。因此，它在治療各種脊椎疾病方面廣受歡迎，例如退化性椎間盤疾病、椎間盤突出、椎管狹窄和椎體骨折。根據美國國家醫學圖書館的數據，隨著影像導航系統、機器人技術和內視鏡技術的進步，微創脊椎 (MIS) 手術取得了顯著進展。美國每年完成的微創脊椎手術超過 40 萬例，其中脊椎融合術是治療脊椎創傷、腫瘤、結構畸形和退化性疾病的常用且成熟的治療方案。

按最終用戶分類：

  • 醫院
  • 門診護理中心
  • 脊椎外科中心
  • 骨科診所
  • 其他

醫院是主要的細分市場

醫院是主要的專科醫療中心，吸引了大量尋求各種脊椎疾病（包括需要手術治療的疾病）的患者。此外，一些醫院設有專門的脊椎中心或科室提供服務，使其成為提供全面護理的首選中心。此外，醫院與脊椎生物製劑製造商和供應商保持著密切的合作，從而提高了設備的效率。 2022年6月，Xenco Medical 獲得美國食品藥物管理局 (FDA) 的批准，並推出了一次性使用的多節段頸椎手術套件 (Multilevel CerviKit)，從而擴大了其面向門診手術中心的設備範圍。該套件包含一整套用於頸椎前路兩節段、三節段和四節段手術的植入物和一次性器械。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據脊椎生物製劑最大市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是脊椎生物製劑最大的區域市場。

北美在市場上的主導地位可以歸因於高度發展的醫療基礎設施、創新醫療技術的高採用率以及龐大的脊椎疾病患者群體。例如，根據美國國家脊髓損傷協會的資料，美國約有 45 萬人患有脊髓損傷 (SCI)。美國每年估計有 17,000 例新發生 SCI 病例，主要源自於脊椎創傷。因此，SCI 族群發病率的上升顯著增加了該地區對治療脊椎疾病的生物製劑的需求。此外，優惠的報銷政策、強大的研發力度以及對微創手術優勢的認知，正在為北美脊椎生物製劑市場帶來收入。

本報告回答的關鍵問題

  • 全球脊椎生物製劑市場有多大
  • 2025-2033年全球脊椎生物製劑市場的預期成長率是多少
  • 推動全球脊椎生物製劑市場的關鍵因素有哪些
  • COVID-19 對全球脊椎生物製劑市場有何影響
  • 根據產品類型，全球脊椎生物製劑市場如何分類？
  • 根據手術類型，全球脊椎生物製劑市場如何分佈
  • 根據最終用戶，全球脊椎生物製劑市場如何分類
  • 全球脊椎生物製劑市場的主要區域有哪些
  • 全球脊椎生物製劑市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 全球脊椎生物製劑市場有多大？ 2025-2033年全球脊椎生物製劑市場的預期成長率是多少？
  • 推動全球脊椎生物製劑市場發展的關鍵因素有哪些？
  • COVID-19 對全球脊椎生物製劑市場有何影響？
  • 根據產品，全球脊椎生物製劑市場如何分佈？
  • 根據手術類型，全球脊椎生物製劑市場如何分佈？
  • 根據最終用戶，全球脊椎生物製劑市場如何分佈？
  • 全球脊椎生物製劑市場的主要區域有哪些？
  • 全球脊椎生物製劑市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球脊椎生物製劑市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 脊椎同種異體移植
    • 關鍵部分
      • 機械加工骨同種異體移植
      • 去礦骨基質
  • 骨移植替代品
    • 關鍵部分
      • 骨形態發生蛋白
      • 合成骨移植
  • 基於單元格的矩陣

第7章：市場區隔：依手術類型

  • 開放性脊椎手術
  • 微創脊椎手術

第 8 章：市場區隔：依最終用戶

  • 醫院
  • 門診護理中心
  • 脊椎外科中心
  • 骨科診所
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Arthrex Inc
    • Alphatec Holdings Inc.
    • Exactech Inc
    • Johnson & Johnson
    • Medtronic plc
    • NuVasive Inc
    • Orthofix Medical Inc.
    • Stryker Corporation
    • Wright Medical Group NV
    • Zimmer Biomet
Product Code: SR112025A4333

The global spine biologics market size reached USD 2.14 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.97 Billion by 2033, exhibiting a growth rate (CAGR) of 3.52% during 2025-2033. The market is driven by the widespread adoption of minimally invasive surgeries (MIS), the growing geriatric population, the growing access to healthcare services on account of inflating income levels, and the increasing incidence of spinal disorders.

Spine Biologics Market Analysis:

  • Major Market Drivers: The spine biologics market research indicates that the market is primarily driven by the increasing prevalence of spinal disorders such as disc disease and spinal stenosis, often related to aging and lifestyle factors.
  • Key Market Trends: There is a noticeable trend toward the use of biologics in spine surgeries to promote quicker recovery and better outcomes, aligning with advancements in medical technologies. In the spine biologics market forecast, the industry will witness ongoing innovation with the integration of artificial intelligence and machine learning technologies to enhance the precision and effectiveness of spine biologics.
  • Geographical Trends: North America currently leads the global market due to its advanced healthcare infrastructure, high healthcare expenditure, and awareness of spinal ailments. Moreover, the Asia-Pacific region is witnessing rapid growth according to the spine biologics market statistics owing to increasing healthcare access, rising economic standards, and a growing geriatric population.
  • Competitive Landscape: Some of the major market players in the spine biologics industry include Arthrex Inc., Alphatec Holdings Inc., Exactech Inc., Johnson & Johnson, Medtronic plc, NuVasive Inc., Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet, among many others.
  • Challenges and Opportunities: The challenges in the market include concerns over the high cost of biologic products and stringent regulatory environments that can delay product launches. As outlined in the spine biologics market overview, the growing collaborations with insurance providers and healthcare facilities hold the potential to improve access to and uptake of biologic treatments generating numerous opportunities.

Spine Biologics Market Trends:

Increasing Prevalence of Spinal Disorders

The growing occurrence of spinal disorders is affecting the spine biologics market growth. In addition, the increasing life expectancy, and lifestyle issues, are spurring the development of degenerative illnesses such as disc disease and spinal stenosis. According to the World Health Organization (WHO) in 2020 approximately 1 in 13 individuals equating to 619 million individuals experienced low back pain (LBP), a 60% increase from 1990. It is further estimated that low back pain cases will increase by around 843 million by 2050 which emphasizes the widespread nature of spinal issues. The rising number of incidences is with the age group of 80 years, and the increasing number of LBP cases occur at the age of 50-55 years. This widespread prevalence necessitates ongoing development and deployment of effective treatments, including biologics, which help promote bone growth and healing, making them critical in treating these pervasive conditions.

Rising Adoption of Minimally Invasive Surgeries (MIS)

Minimally invasive surgeries (MIS) for spinal conditions are preferred due to their less distressful nature and quicker recovery times compared to traditional open surgeries. The global market for minimally invasive surgery is projected to expand at a compound annual growth rate (CAGR) of roughly 6% during 2024-2032 as per the IMARC GROUP. It reached US$ 52.9 Billion in 2023 and anticipates the market to reach US$ 91.0 Billion by 2032. This growth is declarative of a shift in surgical methods that reduce hospital stays and recovery periods, which is particularly beneficial for spine biologics market value.

Growing Geriatric Population

The growing geriatric population is driving the spine biologics market demand. As individuals age, the risk of developing spinal disorders increases, necessitating more frequent and intensive care. As per the data from the UNITED NATIONS population aged 65 and over is expected to rise from 10% in 2022 to 16% in 2050. It is forecasted that individuals aged 65 years or above globally will double the number of children under age 5 and will be equal to the number of 12-year-old children. It means a rising number of age-associated spinal conditions, escalating the demand for treatments that are effective and minimally invasive. For instance, biologics, which aid in the natural healing processes, are particularly suited to meet these needs, aligning with the growing healthcare requirements of an aging global population.

Spine Biologics Market Segmentation:

Breakup by Product:

  • Spinal Allografts
    • Machined Bones Allograft
    • Demineralized Bone Matrix
  • Bone Graft Substitutes
    • Bone Morphogenetic Proteins
    • Synthetic Bone Grafts
  • Cell Based Matrix

Bone graft substitutes account for the majority of the market share

Bone graft substitutes offer an alternative to customary bone grafts, stipulating structural support and facilitating bone healing processes in spinal surgeries. These substitutes embrace synthetic materials, allografts, and demineralized bone matrix, and are advocated for their aptitude to endorse bone fusion and curb the need for harvesting bone from the patient's own body, minimizing surgical complications and recovery time. As per the statistics by IMARC GROUP, the global bone graft and substitute market reached US$3.2 Billion in 2023. It is estimated to reach US$ 5.1 Billion by 2032 with a compound annual growth rate (CAGR) of 5.2% during 2024-2032. Moreover, various advancements in biomaterials, regenerative medicine, and bone graft substitutes are witnessing increasing adoption in spinal procedures, thus positively increasing the spine biologic market value.

Breakup by Surgery Type:

  • Open Spine Surgery
  • Minimally Invasive Spine Surgery

Minimally invasive spine surgery holds the largest share of the industry

Minimally invasive spine surgery is primarily attributed to the growing preference for minimally invasive procedures among patients and healthcare providers. Minimally invasive spine surgery offers several advantages over traditional open surgeries, including smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery times. As a result, it has gained popularity for treating various spinal conditions, such as degenerative disc disease, herniated discs, spinal stenosis, and vertebral fractures. According to the NATIONAL LIBRARY OF MEDICINE, minimally invasive spine (MIS) surgery has advanced significantly with imaging navigation systems, robotics, and endoscopy. More than 400,000 cases are accomplished in the United States annually with spine fusion being the commonly conducted and established treatment options for spine trauma, tumors, structural deformities, and degenerative disorders.

Breakup by End User:

  • Hospitals
  • Ambulatory Care Centers
  • Spinal Surgery Centers
  • Orthopedic Clinics
  • Others

Hospitals represent the leading market segment

Hospitals are major centers for specialized medical care that attract a considerable proportion of patients seeking treatments for several forms of spinal disorders including those that necessitate surgeries. Furthermore, some hospitals have dedicated spine centers or departments where they offer services, making them the preferred centers for comprehensive source care. Besides this, hospitals have strong collaborations with spine biologic manufacturers and suppliers, thereby enhancing the efficiency of the equipment. In June 2022, Xenco Medical broadened its range of devices for ambulatory surgery centers by securing Food and Drug Administration (FDA) clearance and introducing its Multilevel CerviKit for their single use. It comprises a complete suite of implants and single-use instruments for two, three, and four level procedures of the anterior cervical spine.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest spine biologics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for spine biologics.

North America's dominance in the market can be attributed to highly developed healthcare infrastructure, the high rate of innovative medical technologies' adoption, and a large patient pool with spinal disorders. For instance, as per the data from the National Spinal Cord Injury Association, approximately 450,000 individuals reside in the United States with a spinal cord injury (SCI). Annually, an estimated 17,000 new cases of SCI arise in the U.S., predominantly stemming from trauma to the vertebral column. Thus, the increasing incidence of SCI population is significantly escalating the demand for spine biologics to treat disorders across the region. Additionally, favorable reimbursement policies, strong R&D efforts, and awareness of the advantages of minimally invasive surgical procedures are generating the spine biologics market revenue in North America.

Competitive Landscape:

  • The spine biologics market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the spine biologics industry include Arthrex Inc., Alphatec Holdings Inc., Exactech Inc., Johnson & Johnson, Medtronic plc, NuVasive Inc., Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet.
  • At present, key players in the market are investing in research and innovation to develop models that outperform rivals and offer solutions sought by customers. They also work hard to ensure their products remain in the market and meet customers' demands through the development of strategic alliances, acquisitions, and expansions into new markets to penetrate more markets and meet all customer needs. For instance, in October 2023, Orthofix Medical Inc., a prominent global spine and orthopedics corporation unveiled the full commercial release of OsteoCove, which is an innovative bioactive synthetic graft, following its 510k clearance. It is offered in putty and strip forms, meticulously developed to offer exceptional bone-forming capabilities and optimal handling properties for various spine and orthopedic procedures. Moreover, excellent marketing and brand management also make their products highly demanded, which is providing a positive spine biologics market outlook.

Key Questions Answered in This Report

  • 1.How big is the global spine biologics market?
  • 2.What is the expected growth rate of the global spine biologics market during 2025-2033?
  • 3.What are the key factors driving the global spine biologics market?
  • 4.What has been the impact of COVID-19 on the global spine biologics market?
  • 5.What is the breakup of the global spine biologics market based on the product?
  • 6.What is the breakup of the global spine biologics market based on the surgery type?
  • 7.What is the breakup of the global spine biologics market based on the end user?
  • 8.What are the key regions in the global spine biologics market?
  • 9.Who are the key players/companies in the global spine biologics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Spine Biologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Spinal Allografts
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Machined Bones Allograft
      • 6.1.2.2 Demineralized Bone Matrix
    • 6.1.3 Market Forecast
  • 6.2 Bone Graft Substitutes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bone Morphogenetic Proteins
      • 6.2.2.2 Synthetic Bone Grafts
    • 6.2.3 Market Forecast
  • 6.3 Cell Based Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Surgery Type

  • 7.1 Open Spine Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Minimally Invasive Spine Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Spinal Surgery Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Orthopedic Clinics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arthrex Inc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Alphatec Holdings Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Exactech Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Medtronic plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 NuVasive Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Orthofix Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Stryker Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Wright Medical Group N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Zimmer Biomet
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Spine Biologics Market: Major Drivers and Challenges
  • Figure 2: Global: Spine Biologics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Spine Biologics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Spine Biologics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Spine Biologics Market: Breakup by Surgery Type (in %), 2024
  • Figure 6: Global: Spine Biologics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Spine Biologics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Spine Biologics (Spinal Allografts) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Spine Biologics (Spinal Allografts) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Spine Biologics (Bone Graft Substitutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Spine Biologics (Bone Graft Substitutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Spine Biologics (Cell Based Matrix) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Spine Biologics (Cell Based Matrix) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Spine Biologics (Open Spine Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Spine Biologics (Open Spine Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Spine Biologics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Spine Biologics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Spine Biologics (Ambulatory Care Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Spine Biologics (Ambulatory Care Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Spine Biologics (Spinal Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Spine Biologics (Spinal Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Spine Biologics (Orthopedic Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Spine Biologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Spine Biologics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Spine Biologics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Spine Biologics Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Spine Biologics Industry: SWOT Analysis
  • Figure 78: Global: Spine Biologics Industry: Value Chain Analysis
  • Figure 79: Global: Spine Biologics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Spine Biologics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Spine Biologics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Spine Biologics Market Forecast: Breakup by Surgery Type (in Million USD), 2025-2033
  • Table 4: Global: Spine Biologics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Spine Biologics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Spine Biologics Market: Competitive Structure
  • Table 7: Global: Spine Biologics Market: Key Players